We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.98B
2
META icon
Meta Platforms (Facebook)
META
+$997M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$860M
4
WDAY icon
Workday
WDAY
+$691M
5
AMZN icon
Amazon
AMZN
+$616M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$498M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$420M
3
FDX icon
FedEx
FDX
+$350M
4
VALE icon
Vale
VALE
+$340M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$322M

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADCT icon
11351
CALL
ADC Therapeutics
ADCT
$146M
$169K ﹤0.01%
11,500
-65,300
-85% -$1.04M
RYM
11352
RYTHM Inc
RYM
$50.4M
$169K ﹤0.01%
12
-31
-72% -$607K
GALT icon
11353
PUT
Galectin Therapeutics
GALT
$405M
$169K ﹤0.01%
105,100
-26,700
-20% -$51.7K
TRML
11354
DELISTED
Tourmaline Bio
TRML
$169K ﹤0.01%
+1,721
New +$161K
IRD
11355
Opus Genetics
IRD
$307M
$169K ﹤0.01%
52,123
-11,356
-18% -$38.9K
IMGN
11356
CALL
DELISTED
Immunogen Inc
IMGN
$169K ﹤0.01%
35,400
-176,400
-83% -$977K
HYRE
11357
CALL
DELISTED
HyreCar Inc. Common Stock
HYRE
$169K ﹤0.01%
70,800
-22,100
-24% -$68.3K
ZY
11358
PUT
DELISTED
Zymergen Inc. Common Stock
ZY
$169K ﹤0.01%
58,400
-73,900
-56% -$314K
KYN icon
11359
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$168K ﹤0.01%
18,183
-90,098
-83% -$765K
CURO
11360
DELISTED
CURO Group Holdings Corp.
CURO
$168K ﹤0.01%
12,870
-1,989
-13% -$27.4K
EVLO
11361
PUT
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$168K ﹤0.01%
+2,480
New +$206K
CRDF icon
11362
PUT
Cardiff Oncology
CRDF
$73.1M
$167K ﹤0.01%
67,500
-40,600
-38% -$144K
PHXM
11363
CALL
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$167K ﹤0.01%
9,200
-660
-7% -$12.5K
ACH
11364
DELISTED
Alum Corp of China Ltd
ACH
$167K ﹤0.01%
+11,512
New +$175K
CO
11365
DELISTED
Global Cord Blood Corporation
CO
$167K ﹤0.01%
43,547
+11,095
+34% +$46.1K
AREC icon
11366
PUT
American Resources Corp
AREC
$257M
$166K ﹤0.01%
64,700
-35,700
-36% -$72.4K
ARI
11367
Apollo Commercial Real Estate
ARI
$881M
$166K ﹤0.01%
11,903
-3,769
-24% -$50.8K
EMX
11368
DELISTED
EMX Royalty
EMX
$166K ﹤0.01%
76,516
+5,206
+7% +$11.5K
MERC icon
11369
CALL
Mercer International
MERC
$25.9M
$166K ﹤0.01%
+11,900
New +$153K
NGNE icon
11370
CALL
Neurogene
NGNE
$732M
$166K ﹤0.01%
4,420
-265
-6% -$15.5K
REVG
11371
CALL
DELISTED
REV Group
REVG
$166K ﹤0.01%
12,400
+1,200
+11% +$16.4K
SLNH icon
11372
Soluna Holdings
SLNH
$271M
$166K ﹤0.01%
+605
New +$151K
WT icon
11373
CALL
WisdomTree
WT
$3.7B
$166K ﹤0.01%
28,300
-132,400
-82% -$756K
XERS icon
11374
PUT
Xeris Biopharma Holdings
XERS
$1.55B
$166K ﹤0.01%
65,000
-26,500
-29% -$64.7K
ADAP
11375
DELISTED
Adaptimmune Therapeutics
ADAP
$165K ﹤0.01%
80,107
-31,981
-29% -$86.3K
453 454
455
456 457

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.